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Abstract
It has been suggested that the BDNF Val66Met polymorphism modulates episodic memory performance via effects on
hippocampal neural circuitry. However, fMRI studies have yielded inconsistent results in this respect. Moreover, very few
studies have examined the effect of met allele load on activation of memory circuitry. In the present study, we carried out a
comprehensive analysis of the effects of the BDNF polymorphism on brain responses during episodic memory encoding and
retrieval, including an investigation of the effect of met allele load on memory related activation in the medial temporal
lobe. In contrast to previous studies, we found no evidence for an effect of BDNF genotype or met load during episodic
memory encoding. Met allele carriers showed increased activation during successful retrieval in right hippocampus but this
was contrast-specific and unaffected by met allele load. These results suggest that the BDNF Val66Met polymorphism does
not, as previously claimed, exert an observable effect on neural systems underlying encoding of new information into
episodic memory but may exert a subtle effect on the efficiency with which such information can be retrieved.
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Introduction
Brain-Derived Neurotrophic Factor (BDNF) is a secretory
protein that is widely distributed in the human brain with its
expression reduced in neurodegenerative disorders including
Alzheimer’s and Huntington’s disease [1]–[5]. The key function
of BDNF in the adult brain is to regulate synapse functions
including enhancing synaptic transmission, facilitating synaptic
plasticity, particularly long-term potentiation (LTP) [6]–[8], and
promoting synaptic growth (i.e. synaptogenesis) such as regulating
spine density and expression of synaptic proteins [9]–[10]. A
genetic variation in the human BDNF gene, a single nucleotide
polymorphism (SNP) at nucleotide (G196A, rs6265) that converts
Valine to Methionine in the pro-domain (codon 66) of BDNF
protein, has been identified, with in vitro experiments demonstrat-
ing that the Met variant is associated with impaired dendritic
trafficking of BDNF, segregation into regulated secretory vesicles
and synaptic localization, and decreased activity-dependent
secretion (18–30% decrease) [11]–[12].
The role of BDNF in modulating LTP has led to much interest
in the effect of the BDNF Val66Met polymorphism on learning,
memory and underlying neural circuitry. Several fMRI studies
have found effects of the polymorphism on activation in regions
subserving memory, in particular the medial temporal lobe (MTL).
However, there is considerable inconsistency surrounding the
direction of the effect [13], with some studies finding lower
activation in met carriers [14]–[19] and others finding lower
activation in val homozygotes [11] [20] [21].
One possible explanation for this inconsistency is that previous
studies have included variable numbers of met homozygous
subjects in their samples. The met allele is less frequent in the
general population than the val allele and therefore the majority of
studies have grouped met homozygotes with heterozygotes into a
‘met carrier’ group and compared this with a val homozygote
group. If the effect of the polymorphism depends on the number of
met alleles then differences across studies in the relative numbers
of met homozygous and heterozygous subjects in the ‘met carrier’
group may lead to variability in the effect of the polymorphism on
memory related neural activation. Whilst it seems unlikely that this
would lead to opposing results across studies, the difficulty of
recruiting subjects that are homozygous for the met allele means
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that the true effect of met allele load on MTL activation remains
underexplored.
Conflicting results may also be accounted for by the wide
variety of different approaches to controlling for type 1 error
adopted by different studies; Whilst some studies have performed a
small voxel correction (SVC) for the familywise error (FWE) across
the search space e.g. [17] [18], other studies have used
uncorrected statistics (e.g. [11] [20]; [14] [19], with alpha levels
ranging from 0.05 to 0.001 and extent thresholds (minimum
cluster size for significance) ranging from 0 to 10 voxels.. The
majority of these studies have reduced the number of comparisons
carried out by restricting their analyses to regions in the MTL.
However, the MTL is a large region which, depending on voxel
size and the precise boundary used, may contain in the region of
several thousand voxels. Thus, even with an alpha level of 0.001,
without a correction for multiple comparisons we would expect to
see significant effects in several voxels merely by chance.
Moreover, with such a range of statistical approaches, it is perhaps
unsurprising that different studies have observed widely different
results.
An additional source of inter-study variability may arise from
differences in the tasks used to elicit MTL activation. Conflicting
genotype results in some studies may be accounted for by the use
of nonepisodic memory tasks such as the N-back task, e.g. [11]
[15] which often cause deactivation of the hippocampus. Other
studies have used episodic memory tasks in which extended
periods of encoding or retrieval are contrasted with periods of rest,
e.g. [17], making it difficult to rule out confounding effects of
nonmemory processes, e.g. attention, on resulting patterns of
activation. Of the very few studies that have examined the effects
of genotype on activation during successful memory encoding and
retrieval, results are inconsistent, with some showing no genotype
effect [19] and some showing a difference between genotype
groups but only with an uncorrected statistical threshold [20].
Moreover, even direct replication attempts using exactly the same
tasks as previous studies have produced inconsistent results, e.g.
[20], although, as the authors point out, this may be due to
differences in behavioural performance between the two studies.
Thus, there is at present little consistency in the evidence for a
modulatory effect of the BDNF Val66Met genotype on neural
systems directly linked to episodic memory performance.
In the present study, we attempted to provide a definitive
answer to the question of whether the BDNF polymorphism affects
memory related activation by addressing each of the issues
highlighted above. Firstly, we genotyped subjects prior to
recruitment in order to attain sufficient numbers of met
homozygous subjects to examine the effect of met allele load on
activation of memory circuitry. Secondly, for our primary analysis
we avoided the multiple comparisons problem by defining regions
of interest a priori and averaging BOLD signal across voxels
within each region. Finally, we examined effects of the BDNF
polymorphism on neural activation during successful encoding and
retrieval to investigate the extent to which any genotype effects are
related directly to memory processing. For comparability with
previous studies, we examined effects of genotype on a scene
encoding and recognition memory task that was adapted from one
used in a previous study on the effects of the BDNF Val66Met
polymorphism on memory related brain activation [17].
Methods
Ethics Statement
The study was approved by Cambridge South National
Research Ethics Committee (REC reference 11/EE/0360).
Participants provided written consent to participate in the study.
The consent procedure was approved by the Cambridge South
National Research Ethics Committee.
Subjects
Sixty three healthy subjects (41 males), all right-handed, were
recruited for the study from a database of approximately 10,000
subjects with information on the BDNF gene polymorphism, held
at the Phase I GSK Clinical Unit and the Cambridge
BioResource, Cambridge Biomedical Research Centre (CBRC).
Of these 63, three subjects withdrew from the study and two
subjects’ data were excluded from analysis for performance at or
close to chance (below 60% overall correct responses at retrieval).
Of the remaining 58 subjects, 20 (10 males) were homozygous for
the met allele (MetMet), 18 (13 males) were heterozygous (ValMet)
and 20 (14 males) were homozygous for the val allele (ValVal). All
subjects were Caucasian except one who was of mixed ethnicity.
The genotypes in our sample are not in Hardy-Weinberg
Equilibrium. This was intentional - we wanted to recruit an equal
number of subjects from each of the genotype groups to look at
gene-dose effects in a balanced design. The mean age of the
subjects was 40 years (range 19–55 years).
Subjects were screened for eligibility to participate. Exclusion
criteria included (but were not limited to) the following: any
current history of Axis I psychiatric disorders as determined by
MINI neuropsychiatric interview; any previous disease or current
medical condition, which, as judged by the investigator, could
affect the interpretation of data; personal or family history of
epilepsy; positive pre-study HIV, Hepatitis B surface antigen or
positive Hepatitis C antibody result within 3 months of screening;
history of alcohol or substance abuse or dependence in the 6
months prior to screening; regular use of tobacco- or nicotine-
containing products within 6 months prior to screening; use of any
centrally acting medication; positive urine drug test at screening or
when tested at any of the study visits; pregnant females as
determined by positive urine hCG test at screening and testing
days or lactating females; drug dependence by the DSM-IV
criteria within the last 6 months as assessed by the (MINI)
interview.
Procedure
The study was double-blind. Subjects attended a screening
session and two testing sessions on separate days. fMRI scanning
was performed as part of a wider study examining a variety of
neurophysiological and behavioural endpoints, but only the fMRI
data are reported here. fMRI scanning was performed on the first
testing session. Subjects arrived at the GSK Clinical Unit in the
morning and a urine drug screen and alcohol breath test was
performed followed by electrophysiological assessment. fMRI
scanning was performed between 12.30 and 14.30 hours.
Episodic Memory Task
The task used in the current study was a picture encoding/
retrieval task that was modified from that used in previous studies
[17] [22]. The task was composed of an encoding phase and a
retrieval phase. During encoding, subjects viewed a single scene on
each trial and reported, using one of two keys on a button box,
whether the scene was indoor or outdoor. In the retrieval phase,
subjects were again shown a single scene on each trial and this
time reported, using the same two buttons, whether each scene
was old (i.e. they remembered it from the encoding phase) or new.
One half of the retrieval trials were old (the other half were new),
and only one half of the scenes from encoding were tested. In
order to increase the difficulty of the task, ‘new’ scenes were old
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scenes in which the photograph had been taken from a different
viewpoint, and subjects were instructed only to report a scene as
‘old’ if it was exactly the same, i.e. the same scene taken from
exactly the same viewpoint.
There was a 10 minute gap between the encoding and retrieval
phases during which subjects were instructed to close their eyes
and rest without falling asleep. A black screen was presented. After
10 minutes subjects were instructed to open their eyes and advised
that the next stage of the task was about to begin. There were 16
encoding blocks and 16 retrieval blocks per phase, each block
lasting 24 s, with 20 s blocks of passive fixation (baseline)
interleaved. In each block there were 6 trials, leading to 96
encoding trials and 96 retrieval trials in total. Indoor/outdoor and
old/new trials were pseudorandomly presented, with the con-
straint that there were three of each trial type in each block. On
each trial, a fixation cross was presented for 1000 ms, followed by
the target scene for 3000 ms, during which time the subject was
required to make their response.
fMRI Data Acquisition and Analysis
Subjects were scanned at the Wolfson Brain Imaging Centre in
Cambridge, UK. Scanning was performed in a single run
including an initial resting state session (not reported here), the
encoding phase, the retention interval of further rest, and the
retrieval phase. A total of 32 gradient-echo T2*-weighted echo-
planar images were acquired per volume, containing blood
oxygenation level-dependent (BOLD) contrast. The first six
volumes were treated as ‘‘dummy’’ scans and discarded to avoid
T1-equilibration effects. The 32 images (slices) contained 64664
pixels, were positioned at 30u to the anterior commissure–posterior
commissure plane, and were 3 mm thick with a 0.5 mm interslice
gap. The repetition time between volumes was 2000 ms, with an
echo time of 30 ms and 90u flip angle. Data were analyzed using
statistical parametric mapping in the SPM8 software (www.fil.ion.
ucl.ac.uk). Volumes were realigned (corrected for head motion),
slice-time corrected, then spatially normalized to a standard
template in MNI space, and spatially smoothed with a Gaussian
kernel (8 mm full width at half-maximum). The time series in each
session were high-pass filtered (with cutoff frequency 1/120 Hz)
and serial autocorrelations were estimated using an AR(1) model.
The fMRI timeseries for each subject were modeled by two,
orthogonal approaches. In the ‘‘epoch’’ model, encoding and
retrieval blocks were modeled as epochs (boxcar functions) of 24 s
and 20 s, convolved with a canonical hemodynamic response
function (HRF). This model was used to test neural activity related
to general encoding and retrieval states (regardless of memory
success for individual trials), as was done in some prior fMRI
studies [17] [18] [20]. In the ‘‘event’’ model, on the other hand,
each trial within an encoding or retrieval block was modelled as a
3 s boxcar convolved with the canonical HRF, and those trials
split into two types (separate regressors): one for stimuli
remembered; the other for stimuli forgotten (plus a third type
for correct rejections of new items for the retrieval model). This
model was used to test for neural activity related specifically to
successful encoding or retrieval. This resulted in 4 separate GLMs
for each subject:
1. Event encoding model – including separate regressors for
subsequent hits and subsequent misses modelled on a trial-by-
trial basis.
2. Event retrieval model – including separate regressors for hits,
misses and correct rejections modelled on a trial-by-trial basis.
3. Epoch encoding model – including separate regressors for
encoding task and rest modelled on a block-by-block basis.
4. Epoch retrieval model – including separate regressors for
retrieval task and rest modelled on a block-by-block basis.
These general linear models (GLMs) were fit to every voxel in a
least squares sense, i.e, a mass univariate analysis was conducted
that resulted in images of parameter estimate (‘‘beta’’) in each
voxel for each regressor.
Given previous results showing effects of the BDNF polymor-
phism on memory-related activation in the medial temporal lobe
(MTL), specifically hippocampus and parahippocampal gyrus, our
primary analyses focused on these regions.
Two different second level (group) analyses were carried out –
one in which we examined mean activation across ROIs and
another in which we examined activation on a voxelwise basis.
Group Analysis 1 – Mean activation across voxels. In the
first analysis, we defined four structural ROIs using the AAL atlas
and marsbar toolbox [23] – left hippocampus, right hippocampus,
left parahippocampal gyrus and right parahippocampal gyrus. For
each of these regions, individual subjects’ mean beta values across
all voxels were extracted for the following contrasts using Marsbar,
and ANOVAs/t-tests were computed in SPSS.
1. Retrieval: Hits vs correct rejections.
2. Retrieval: Hits vs misses.
The above two contrasts both measure activation related to
successful memory retrieval.
3. Encoding: Subsequent hits vs subsequent misses. This
contrast reveals activation during encoding trials that
predicts subsequent retrieval success.
4. Retrieval blocks vs rest blocks. This contrast reveals regions
activated during retrieval task performance relative to a
resting baseline and was performed for consistency with
previous studies.
5. Encoding blocks vs rest blocks: This contrast reveals regions
activated during encoding task performance relative to a
resting baseline and was performed for consistency with
previous studies.
Effects of group on mean activation in each ROI were
examined using repeated measures ANOVAs with ROI as the
within-subjects factor and group as the between-subjects factor.
Where a significant main effect of group or ROI x group
interaction was observed, these were followed up with independent
samples t-tests examining effects in each ROI individually.
Group Analysis 2 – Voxelwise analysis. In addition to
estimating the average activation across voxels within each
anatomical ROI, we also performed a voxelwise search for group
effects within these regions, using the ROIs to perform a small-
volume correction (SVC) of the family-wise error rate (FWE)
across the entire mask. ROIs were defined using the AAL atlas and
the analysis was carried out using Pickatlas and SPM8. This
second, voxelwise approach allows for potential functional
inhomogeneity within the MTL (that would be lost by averaging
over all voxels), and also provides consistency with some previous
studies that performed masked voxelwise analyses across the MTL
[11] [17]–[20].
For this second, voxelwise analysis, beta images from each of the
four first level GLMs (event encoding, event retrieval, epoch
encoding and epoch retrieval) were entered into four separate
group GLMs in SPM8, each of which implemented an Analysis of
Variance (ANOVA), with the factors group (MetMet, ValMet,
ValVal) and memory condition, treating subject as a random
effect. Note that each ANOVA assumed a single pooled error [24],
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whose nonsphericity was estimated by Restricted Maximal
Likelihood estimation on data combined across ‘‘active’’ voxels.
If these voxels differ only in the scaling of the same error
correlation, this pooling of the error is the most sensitive statistical
approach. Nonetheless, to allow for the possibility that the error
correlation differed across voxels, we repeated the ANOVAs after
partitioning the error into separate terms for each ANOVA effect
(by constructing contrasts of the data and fitting a separate GLM
for each effect in SPM; [24]). There were negligible differences
between the pattern of significant results when pooling versus
partitioning the error (e.g, no suprathreshold ANOVA effects
when partitioning the error that were not also present when
pooling the error), so we report the more sensitive pooled error
results here.
For both of the group analyses, several planned comparisons
were tested. Firstly, in an attempt to replicate previous studies, we
combined MetMet and ValMet subjects into a ‘met carrier’ group
and compared this with the val homozygous group. Secondly, we
compared the met homozygous (MetMet) group with the val
homozygous (ValVal) group – this comparison should show the
strongest effect if it is met allele load dependent. Where significant
group effects were observed in either of the above comparisons, we
followed these up with a comparison of the met homozygous
(MetMet) group with the heterozygous (ValMet) group in order to
examine whether activation was affected by the number of met
alleles carried (i.e. effect of met load). The rationale here was firstly
to look for an overall effect of the met allele and secondly to
examine whether that effect depended on the number of met
alleles carried – for this reason, met allele load effects were not
explored where no group differences in either of the first two
comparisons were observed.
Finally, in order to explore genotype effects in brain regions
associated with task performance but outside the MTL, we
performed whole brain analyses of task effects across all subjects
for successful encoding and retrieval and performed a search
across all voxels in these regions to examine group effects,
controlling the family-wise error rate (FWE) across the entire
brain.
Behavioural Data Analysis
Behavioural data were subjected to signal detection analysis.
Briefly, trials were divided into hits (old scenes correctly labelled as
old), misses (old scenes incorrectly labelled as new), correct
rejections (new scenes correctly labelled as new) and false alarms
(new scenes incorrectly labelled as old) and d prime (d9) was
calculated using the formula d9= z(H)2z(FA), where z(H) is the z-
transform of the proportion of hits and z(FA) is the z-transform of
the proportion of false alarms.
Genotyping
DNA was extracted from blood samples via standard methods
and genotyped for the BDNF Val66Met SNP via TaqMan
50exonuclease assay (Applied Biosystems, Foster City, CA, USA).
Results
Demographics
One way ANOVA revealed that the mean age of subjects did
not differ significantly between the three genotype groups,
F(2,55) = 0.49, p = 0.62. (MetMet M=41.75 SEM=2.2, ValMet
M=40.28 SEM=2.52, ValVal M=38.45, SEM=2.51).
Chi-square revealed that there was no significant difference in
gender across the three genotype groups, x2(2) = 2.53, p = 0.28.
Behavioural Results
An independent samples t-test comparing met carriers (MetMet
and ValMet) with val homozygotes (ValVal) revealed no
significant effect of genotype on d9 (MetMet M=1.07
SEM=0.1, ValMet M=0.97 SEM=0.08, ValVal M=1.08
SEM=0.08, t(57) =2.95, p = .34) or on proportion of hits(Met-
Met M=0.59 SEM=0.03, ValMet M=0.57 SEM=0.03, ValVal
M=0.63 SEM=0.03, t(57) =21.56, p = .12), or proportion of
false alarms, (MetMet M=0.22 SEM=0.03, ValMet M=0.23
SEM=0.03, ValVal M=0.24 SEM=0.02, t(57) =2.26, p = .8).
There was also no significant effect of genotype when comparing
met homozygotes and val homozygotes: d9, t(38) =2.71, p = .48;
percentage of hits, t(38) =21.5, p = .14; percentage of false alarms,
t(38) =2.34, p = .73.
FMRI Results
Summary statistics for all fMRI and behavioural results are
presented in File S1, tables S1 and S2 in File S1.
Encoding. One sample t-test revealed significantly greater
activation, averaging across all three groups, during successful
encoding (subsequent hits vs subsequent misses) when averaging
across all voxels within all 4 anatomical MTL ROIs, t(57) = 2.92,
p = .005. Individual one-sample t-tests on average activation across
voxels within each ROI confirmed significantly increased activa-
tion in all four ROIs: left hippocampus, t(57) = 2.42, p = .02, right
hippocampus, t(57) = 2.06, p = .04, left parahippocampal gyrus,
t(57) = 2.99, p = 0.004 and right parahippocampal gyrus,
t(57) = 3.43, p = 0.001. These ROI effects were broadly confirmed
in a whole brain analysis, which showed two large clusters of
voxels that showed increased activation for subsequent hits than
subsequent misses extending bilaterally from occipital cortex into
fusiform gyrus, parahippocampal gyrus and hippocampus
(Figure 1A).
Repeated measures ANOVA comparing successful encoding
activation in met carriers (MetMet and ValMet) and val
homozygotes in the MTL ROIs revealed no main effect of group,
F(1,57) = .32, p = .57 and no group x ROI interaction,
F(1,57) = 1.16, p= .33. There was also no significant difference
between met homozygotes and val homozygotes, F(1,38) = .009,
p = .92 and no group x ROI interaction, F(1,38) = .48, p = .69.
Voxelwise searches across bilateral hippocampus and parahippo-
campal gyrus, and across regions activated in the whole-brain task
analysis, with a FWE-corrected p-value of 0.05, revealed no voxels
that showed a significant effect of group on activation during
successful encoding, comparing val homozygotes with either met
homozygotes or with met carriers.
Repeated measures ANOVA comparing activation during
encoding independent of subsequent retrieval success (encoding
blocks – rest blocks) in met carriers and val homozygotes in the
MTL ROIs revealed no main effect of group, F(1,57) = 1.08, p= .3
and no group x ROI interaction, F(1,57) = 1.67, p= .18. There
was also no significant difference between met homozygotes and
val homozygotes, F(1,38) = 1.01, p = .32 and no group x ROI
interaction, F(1,38) = .4, p = .75. A voxelwise search across
bilateral hippocampus and parahippocampal gyrus with a FWE-
corrected p-value of 0.05 also revealed no voxels in which
encoding-related activation independent of subsequent success
differed significantly by group, when comparing val homozygotes
with either met homozygotes or met carriers.
Retrieval. Activation averaged across all four MTL ROIs
and across all three groups was not significantly greater for hits
relative to misses, one sample t-test: t(57) = 1.06, p = .29, or for hits
vs correct rejections, one sample t-test: t(57) = 1.16, p = .25. Whole
brain analysis of task effects showed a pattern of activation that
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was similar for hits versus misses and for hits versus correct
rejections involving activation in several regions, including
bilateral parietal cortex, caudate nucleus, inferior frontal cortex
and anterior cingulate cortex (figure 1B+C).
Repeated measures ANOVA comparing hits with misses in met
carriers and val homozygotes in the MTL ROIs revealed no main
effect of group, F(1,57) = 1.96, p = .17 and no group x ROI
interaction, F(1,57) = .13, p= .94. There was also no significant
group difference between met homozygotes and val homozygotes,
F(1,39) = .19, p = .67, and no ROI x group interaction,
F(1,39) = 1.68, p = .18.
Repeated measures ANOVA comparing hits with correct
rejections in met homozygotes and val homozygotes in the MTL
ROIs revealed no significant main effect of group, F(1,57) = 2.12,
p = .15 and no significant group x ROI interaction, F(1,57) = 2.47,
p = .07. The same ANOVA comparing met carriers and val
homozygotes in the MTL ROIs revealed no significant main effect
of group, F(1,57) = 2.27, p = .14. However there was a significant
group x ROI interaction, F(1,57) = 2.70, p = .048. T-tests exam-
ining each ROI individually revealed significantly greater activa-
tion in met carriers in the right hippocampus, t(57) = 2.14, p= .04
(Figure 2) but not in the left hippocampus, t(57) = 1.61, p = .11, left
parahippocampal gyrus, t(57) = .44, p= .66 or right parahippo-
campal gyrus, t(57) = 1.58, p= .12. An independent samples t-test
comparing successful retrieval related activation (hits-correct
rejections) in the right hippocampus in met homozygotes and
heterozygotes (i.e. MetMet vs ValMet) revealed no significant
effect of the number of met alleles on activation in this region,
t(57) = .04, p = .97.
Voxelwise searches across bilateral hippocampus and para-
hippocampal gyrus, and across regions activated in the whole-
brain task analysis, with a FWE-corrected p-value of 0.05, revealed
no voxels which showed a significant effect of group on activation
during successful retrieval (for either hits versus misses or hits
versus correct rejections) comparing val homozygotes with either
met homozygotes or with met carriers.
Finally, we also examined the effect of genotype on retrieval-
related activation regardless of retrieval success (retrieval blocks vs
rest blocks). Repeated measures ANOVA showed no significant
difference between met carriers and val homozygotes in the MTL
ROIs, F(1,57) = .007, p = .93 and no group x ROI interaction,
F(1,57) = .95, p= .42. There was also no significant difference
between met homozygotes and val homozygotes, F(1,38) = .15,
p = .7 and no group x ROI interaction, F(1,38) = 1.02, p = .38. A
voxelwise search across bilateral hippocampus and parahippo-
campal gyrus revealed no voxels that showed a significant group
effect on activation during retrieval regardless of its success that
survived p,.05 SVC, FWE-corrected, comparing val homozy-
gotes with either met homozygotes or with met carriers.
Figure 1. Whole brain task effects: Statistical Parametric Maps overlaid on MNI template brain showing regions that show
significant activation during successful encoding (subsequent hits versus subsequent misses, panel A) or successful retrieval (hits
versus misses, panel B, or hits versus correct rejections, panel C). SPMs are thresholded at p,0.001 uncorrected for multiple comparisons for
display purposes. However, peak voxels survive at FWE p,0.05 corrected for multiple comparisons.
doi:10.1371/journal.pone.0074133.g001
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Effect of Age on Memory-Related Activation
Because previous genetic studies have found moderating effects
of age on genetic effects on MTL activation, e.g. [25], we repeated
all of the fMRI analyses including age as a covariate in the models,
and examined effects of group and group x age interactions.
Inclusion of the age covariate did not alter any of the non-
significant results. However, inclusion of age as a covariate in the
ANOVA comparing activation during successful retrieval (hits vs
CRs) in met carriers and ValVal subjects resulted in the group x
ROI interaction no longer reaching significance, F(1,57) = 2.36,
p = .08. A one-way ANOVA including age as a covariate focusing
on the right hippocampus also failed to reveal a significant
difference between met carriers and ValVal subjects,
F(1,57) = 2.36, p = .13.
Correlation Between Memory Performance and
Activation
We examined correlations between activation and memory
performance in the right hippocampus as this was the only region
that showed a significant effect of group on activation during
successful memory retrieval. There was a significant negative
correlation between memory performance (d9) and activation
during successful memory retrieval (hits – correct rejections beta
values) in right hippocampus r =20.3, p = .02 (figure 3). We also
examined correlations separately in met carriers and val homo-
zygotes. There was a significant negative correlation between
memory performance and activation in met carriers, r =2.39,
p = .01 but not in val homozygotes, r = .06, p= .79. Comparison of
the regression slopes of beta values against d9 across genotypes
confirmed a significantly stronger correlation in met carriers than
in val homozygotes, t(52) = 1.89, p (one-tailed) = .03. Comparison
of the regression slopes in met homozygotes and heterozygotes
revealed no significant difference in the number of met alleles on
the strength of this correlation, t(52) = 0.84, p (one-tailed) = .20.
Discussion
In the present study, we carried out a comprehensive analysis of
the effects of the BDNF Val66Met polymorphism on brain activity,
as measured by fMRI, during encoding and retrieval of episodic
memories. In contrast to previous fMRI studies using very similar
paradigms, we found no evidence of differences between BDNF
genotypes (MetMet, ValMet and ValVal) on encoding-related
activation in the hippocampus or parahippocampal gyrus, despite
multiple different analyses of the type used in the previous studies.
We also found no significant effect of the BNDF Val66Met
polymorphism on behavioural performance. In fact, the only
group difference that surpassed conventional significance levels
concerned activation during retrieval in right hippocampus: Met
carriers showed a greater difference in the comparison of correct
recognition of studied scenes (hits) versus correct rejection of
similar, but unstudied, foil scenes. However, when age was
included as a covariate, the difference between met carriers and
val homozygotes was no longer significant.
Prior fMRI studies on the effects of the BDNF polymorphism on
memory-related neural activation have found conflicting results,
with some showing decreased activation in met carriers [14]–[19]
and others showing increased activation in met carriers, relative to
val homozygotes [11] [20] [21]. In the introduction, we outlined
three possible explanations for these discrepancies, which we
discuss in turn below in light of the present findings.
The first possible explanation we put forward was that previous
studies have grouped variable numbers of MetMet and ValMet
subjects into a ‘Met carrier’ group, which may lead to variable
effects on hippocampal activation if the true effect of the
polymorphism is met load dependent. The present results are
inconsistent with this account. Although we observed greater
activation during successful retrieval in met carriers relative to val
homozygotes in the right hippocampus, there was no significant
difference in activation for this contrast in this region between
subjects who carry one met allele (ValMet) and those who carry
two met alleles (MetMet).
Another possible explanation for different results across studies
is the use of a variety of different paradigms to elicit MTL
activation. Different results across studies may reflect task
differences such as the extent to which MTL activation can be
directly related to the process of laying down and retrieving
information in memory. In the present study, we addressed this
Figure 2. Mean beta values for hits, misses and correct rejections during the retrieval phase in right hippocampus by BDNF
Val66Met genotype. Error bars represent SEM.
doi:10.1371/journal.pone.0074133.g002
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issue by performing two analyses – data from each phase
(encoding and retrieval) were analysed both on a trial-by-trial
basis, revealing MTL activation directly related to successful
memory performance, and also on a block-by-block basis to
provide consistency with some previous studies, e.g. [17]. For the
encoding phase, the method of analysis made no difference to the
results – there was no effect of group when we analysed MTL
activation on a trial-by-trials basis or on a block-by-block basis.
For the retrieval phase, we did observe a group effect when
examining MTL activation on a trial-by-trial basis but not on a
block-by-block basis. Thus, our results provide partial support for
this account, although it should be noted that several previous
studies found significant effects of the BDNF polymorphism on
MTL activation using block designs, which we failed to replicate.
The third possible explanation for discrepancies in results across
studies concerns differences in the method used to control for type
1 error (false positives). Prior studies have adopted a variety of
approaches to correcting for the multiple comparisons carried out
in voxelwise analyses of fMRI data, with some studies performing
a small volume correction for the familywise error rate, e.g. [17]
[18] and others performing no correction, e.g. [11] [14] [19] [20].
In the present study, we addressed this issue by performing our
primary analyses on mean activation across all voxels in each ROI,
thereby eliminating the multiple comparisons problem. Using this
method, we found no strong evidence for an effect of the BDNF
polymorphism on MTL activation. The drawback of this method
is that it may miss more fine-grained effects in subsets of voxels
within each ROI. Therefore, in follow-up analyses we also
examined MTL activation on a voxel-by-voxel basis. With the
appropriate correction for multiple comparisons, we observed no
significant group differences during either encoding or retrieval
using this method. In a further exploratory analysis, we also
examined differences in activation between genotypes using
uncorrected statistics. With an uncorrected threshold of
p,0.001, we observed a difference in activation between val
and met homozygotes during successful retrieval in four voxels,
which, with a search area of approximately four thousand voxels,
is precisely the number that we would expect to show a significant
difference merely by chance. Thus, our results demonstrate the
real possibility of type 1 error occurring in between-group
comparisons of BOLD signal when using uncorrected alpha levels.
One solution to the problem of inconsistent results across studies
is to perform a meta-analysis in an attempt to identify the true
effect of the BDNF polymorphism on MTL activation. A recent
study did this for all prior fMRI studies on the effects of the BDNF
polymorphism on hippocampal activation, and found that there
was a consistent and relatively large effect size across studies, with
met carriers showing reduced hippocampal activation relative to
val carriers during memory performance [26]. Unfortunately,
however, the meta-analysis itself failed to take into account the
multiple comparison problem, by calculating effect sizes from
voxels that showed the greatest difference between groups in the
original studies, thereby potentially providing greatly inflated effect
size estimates (for a full analysis of this problem see [13]). Thus,
there is at present no evidence for a consistent effect of the BDNF
polymorphism on MTL activation across studies.
Although we observed some evidence for group differences in
successful retrieval activation when averaging activation across
voxels in each ROI, there are several reasons to be cautious in
over-interpreting these results. Firstly, the effects were confined to
the comparison of hits versus correct rejections, and were not
observed in the comparison of hits versus misses. Secondly, the
effect of group was confined to the right hippocampus during
successful retrieval, and the hippocampus was not strongly
associated with performance of this phase of the task. Given the
strong link between MTL activation and successful encoding in the
present study, any effect of the BDNF Val66Met polymorphism on
MTL memory circuitry should be observable during the encoding
phase. Finally, when we included age as a covariate in the model,
the difference between met carriers and val homozygotes in
activation during successful retrieval was non-significant, suggest-
ing that at least some of the variance in hippocampal activation
apparently due to genetic differences may in fact be driven by age
differences. In summary, significant group effects occurred in a
single analysis in the context of a wide-ranging investigation of
genotype effects and may not be especially robust.
These caveats aside, the present findings are consistent with a
subset of prior studies that have found increased hippocampal
activation in met carriers [11] [20] [21] [27] which may reflect
some form of inefficient processing or compensatory activation.
Consistent with this notion, we observed a negative correlation
between activation during successful retrieval and memory
performance, suggesting that subjects who performed more poorly
on the task required greater levels of hippocampal activation.
Moreover, this correlation was significantly stronger in met
carriers, suggesting that neural inefficiency or compensation in
Figure 3. Scatterplots showing correlations between activation during successful retrieval (hits – correct rejections beta value – y
axis) in right hippocampus and memory performance (d9 – x axis) in met carriers (left panel) and val homozygotes (right panel).
doi:10.1371/journal.pone.0074133.g003
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the hippocampus may be more pronounced in this group. An
alternative interpretation is that increased activation in met
carriers itself represents a marker of impaired neural processing
[28], consistent with the view that excess hippocampal activation
may contribute to memory impairment and may be associated
with widespread degenerative processes in prodromal Alzheimer’s
disease [29] [30].
Finally, we observed no evidence of differences between BDNF
genotypes on behavioural memory performance. Many prior
studies have examined the effect of the BDNF Val66Met
polymorphism on episodic memory and some have found
impaired performance in met allele carriers [31]–[36]. However,
some of the largest studies, that have included several hundred
subjects in their samples, e.g. [37]–[39] have failed to replicate the
results of these smaller studies, calling into question the robustness
of the behavioural effect. Furthermore, a recent meta-analysis of
behavioural studies [40] concluded that there was no consistent
effect of the polymorphism on any cognitive process. Thus, our
findings are consistent with the prior literature in showing no
significant effect of the BDNF Val66Met polymorphism on
episodic memory performance.
It is of course possible that our failure to replicate previous
findings reflects a type II error. Possible reasons for a type II error
include differences between the present study and previous studies
in terms of demographic characteristics such as age or IQ
(although our random effects model should account for subject-to-
subject variation in such factors) and the fact that the fMRI part of
the study was run as part of a wider examination of multiple
cognitive and neurophysiological endpoints, which may have led
to unusual effects on neurocognitive function. On the other hand,
the task we used was clearly suitable for examining group effects
on hippocampal activation as we observed highly significant main
effects of successful encoding in brain regions that are consistent
with many previous fMRI studies of episodic memory. Moreover,
we used a comparable or greater sample size relative to previous
studies, arguing against the possibility that the study was
underpowered.
If the present findings are not due to a type II error, what are
the implications for the role of BDNF in hippocampal-based
memory processes? Clearly, BDNF plays an important role in
synaptic plasticity, as evidenced by preclinical evidence for its
ability to modulate LTP. However, the effects of the BDNF
polymorphism on neural systems underlying episodic memory that
are known to depend on synaptic plasticity and LTP are
apparently less robust. One possible explanation for this discrep-
ancy is the huge leap in complexity involved in making the
transition from in vitro studies to studies of systems level memory
systems. There may simply be too many complex factors, such as
multiple interacting brain regions, SNPs and psychological
processes, that converge at the systems level to mask effects that
operate at the level of individual synaptic processes. Alternatively,
fMRI may be too blunt a tool to detect such effects, although
arguments for the use of neuroimaging in detecting endopheno-
types for psychiatric disorders tend to revolve around the claim
that imaging methods provide superior sensitivity to such
intermediate cognitive biomarkers than do behavioural assays.
Moreover, as noted above, the behavioural literature on the
cognitive effects of the BDNF polymorphism appear to be equally
inconsistent.
In summary, we found no significant effect of the BDNF
polymorphism on hippocampal or parahippocampal activation
during memory encoding or on behavioural task performance.
Increased activation in right hippocampus during successful
retrieval was observed in met carriers relative to val homozygotes
suggesting inefficient neural activation, but this was restricted to a
specific contrast and analysis, was not dependent on met allele
load, and may have been driven by age differences. The present
results do not provide strong support for the hypothesis that the
BDNF Val66Met polymorphism exerts a robust effect on neural
circuitry linked to episodic memory.
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